Search

everythinglearnresearchcommunity

for

Search:↓

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

Minoxidil helps hair grow, especially in people with mild hair loss.

A lotion with 5% minoxidil boosts the immune response in guinea pigs.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Targeted immune modulation can help achieve stable remission in alopecia areata.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Increased T cell activity may predict hair regrowth success with minoxidil in severe alopecia areata.

Finasteride may help treat Neutrophil Actin Dysfunction by reducing LSP1 gene activity.

Sudden hair whitening may be linked to immune system activity.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

The assay effectively identifies compounds that affect immune cell activation.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

BTNL2 helps protect hair follicles from immune attacks.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Topical gabapentin was safe and effective for treating scalp symptoms and promoting hair regrowth in cicatricial alopecias.

Special cells can help regrow hair in alopecia areata.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.